Riskpilot← Back to searchSign inGet full accessSTEINKOPF MEDICAL AS
ASActiveOrg 925018112Energivegen 20, 4056 TanangerWholesale of pharmaceutical and medical goods · NACE 4646Est. 20200 employees
Revenue 2025
NOK 10K
+19% vs 2024
EBITDA margin
-1975.4%
-119% vs 2024
Equity ratio
99.9%
Financial strength
Net profit 2025
NOK -194K
-119% vs 2024
| Revenue | NOK 10K | +19% |
| EBITDA | NOK -194K | -119% |
| Net profit | NOK -194K | -119% |
| Total assets | NOK 66K | -75% |
| Equity | NOK 66K | -75% |
| Employees | 0 | — |
Legal name
STEINKOPF MEDICAL AS
Org number
925018112
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
4. mai 2020
Share capital
NOK 1 000 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Utvikling, kjøp, markedsføring og salg av medisinsk utstyr til helseforetak og andre aktører innen helsesektoren samt å investere i og eie aksjer, finansielle instrumenter og andeler i andre selskaper, med formål om å bidra til utvikling av slike selskaper og verdiskapning for selskapets aksjonærer, samt annen virksomhet som står i naturlig forbindelse med forannevnte.
Address
Energivegen 20, 4056 Tananger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 126 314 | 36 248 | 294 | 8 | 10 |
| Staff expenses | −371 | −371 | −25 | −0 | −0 |
| EBITDA | 14 040 | −4 477 | −943 | −89 | −194 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 14 040 | −4 477 | −943 | −89 | −194 |
| Net financials | −2 225 | −255 | −85 | −0 | 0 |
| Profit before tax | 11 816 | −4 732 | −1 029 | −89 | −194 |
| Tax | 2 600 | −0 | −0 | −0 | −0 |
| Net profit | 9 216 | −4 732 | −1 029 | −89 | −194 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 33 315 | 2 655 | 537 | 265 | 66 |
| Equity | 6 110 | 1 378 | 349 | 260 | 66 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 27 206 | 1 278 | 188 | 4 | 0 |
| Total debt | 27 206 | 1 278 | 188 | 4 | 0 |
EBITDA margin
-1975.4%
This company
15.8%
Market median
-12603% vs market
20212025
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
-292.6%
This company
18.4%
Market median
-1690% vs market
20212025
Net profit margin
-1975.4%
This company
8.1%
Market median
-24488% vs market
20212025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
GK Chief Executive Officer | Chief Executive Officer | 2020 |
TN Deputy Member | Deputy Member | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50.5% | 50.5% | 2024 | |
| Company | 49.5% | 49.5% | 2022 | |
| Company | 49.5% | 49.5% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gks Holding As
STEINKOPF MEDICAL AS Board members of STEINKOPF MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gaute Kolnes Steinkopf | Chief Executive Officer | 0 companies |
| Terje Nyman | Deputy Member | 0 companies |
| Eimund Sletten | Chairman | 0 companies |
| Sturla Sand | Board of Directors | 0 companies |